ID   TRI63_RAT               Reviewed;         351 AA.
AC   Q91Z63;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   02-OCT-2024, entry version 156.
DE   RecName: Full=E3 ubiquitin-protein ligase TRIM63;
DE            EC=2.3.2.27;
DE   AltName: Full=Muscle-specific RING finger protein 1;
DE            Short=MuRF-1;
DE            Short=MuRF1;
DE   AltName: Full=RING-type E3 ubiquitin transferase TRIM63 {ECO:0000305};
DE   AltName: Full=Tripartite motif-containing protein 63;
GN   Name=Trim63; Synonyms=Murf1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, INDUCTION, AND FUNCTION.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11679633; DOI=10.1126/science.1065874;
RA   Bodine S.C., Latres E., Baumhueter S., Lai V.K.-M., Nunez L., Clarke B.A.,
RA   Poueymirou W.T., Panaro F.J., Na E., Dharmarajan K., Pan Z.-Q.,
RA   Valenzuela D.M., DeChiara T.M., Stitt T.N., Yancopoulos G.D., Glass D.J.;
RT   "Identification of ubiquitin ligases required for skeletal muscle
RT   atrophy.";
RL   Science 294:1704-1708(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11927605; DOI=10.1083/jcb.200108089;
RA   McElhinny A.S., Kakinuma K., Sorimachi H., Labeit S., Gregorio C.C.;
RT   "Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric
RT   M-line and thick filament structure and may have nuclear functions via its
RT   interaction with glucocorticoid modulatory element binding protein-1.";
RL   J. Cell Biol. 157:125-136(2002).
RN   [4]
RP   INDUCTION.
RX   PubMed=12782319; DOI=10.1016/s0014-5793(03)00505-2;
RA   Dehoux M.J.M., van Beneden R.P., Fernandez-Celemin L., Lause P.L.,
RA   Thissen J.-P.M.;
RT   "Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle
RT   after LPS injection.";
RL   FEBS Lett. 544:214-217(2003).
RN   [5]
RP   INDUCTION.
RX   PubMed=12672461; DOI=10.1016/s1357-2725(02)00341-2;
RA   Wray C.J., Mammen J.M.V., Hershko D.D., Hasselgren P.-O.;
RT   "Sepsis upregulates the gene expression of multiple ubiquitin ligases in
RT   skeletal muscle.";
RL   Int. J. Biochem. Cell Biol. 35:698-705(2003).
RN   [6]
RP   INDUCTION.
RX   PubMed=14718385; DOI=10.1096/fj.03-0610com;
RA   Lecker S.H., Jagoe R.T., Gilbert A., Gomes M., Baracos V., Bailey J.,
RA   Price S.R., Mitch W.E., Goldberg A.L.;
RT   "Multiple types of skeletal muscle atrophy involve a common program of
RT   changes in gene expression.";
RL   FASEB J. 18:39-51(2004).
RN   [7]
RP   FUNCTION.
RX   PubMed=15596539; DOI=10.1083/jcb.200402033;
RA   Arya R., Kedar V., Hwang J.R., McDonough H., Li H.-H., Taylor J.,
RA   Patterson C.;
RT   "Muscle ring finger protein-1 inhibits PKC-epsilon activation and prevents
RT   cardiomyocyte hypertrophy.";
RL   J. Cell Biol. 167:1147-1159(2004).
RN   [8]
RP   INDUCTION.
RX   PubMed=15827064; DOI=10.1152/ajpendo.00591.2004;
RA   Hong-Brown L.Q., Pruznak A.M., Frost R.A., Vary T.C., Lang C.H.;
RT   "Indinavir alters regulators of protein anabolism and catabolism in
RT   skeletal muscle.";
RL   Am. J. Physiol. 289:E382-E390(2005).
RN   [9]
RP   INDUCTION.
RX   PubMed=15963672; DOI=10.1016/j.exger.2005.04.005;
RA   DeRuisseau K.C., Kavazis A.N., Powers S.K.;
RT   "Selective downregulation of ubiquitin conjugation cascade mRNA occurs in
RT   the senescent rat soleus muscle.";
RL   Exp. Gerontol. 40:526-531(2005).
CC   -!- FUNCTION: E3 ubiquitin ligase. Mediates the ubiquitination and
CC       subsequent proteasomal degradation of CKM, GMEB1 and HIBADH. Regulates
CC       the proteasomal degradation of muscle proteins under amino acid
CC       starvation, where muscle protein is catabolized to provide other organs
CC       with amino acids. Inhibits de novo skeletal muscle protein synthesis
CC       under amino acid starvation. Regulates proteasomal degradation of
CC       cardiac troponin I/TNNI3 and probably of other sarcomeric-associated
CC       proteins. May play a role in striated muscle atrophy and hypertrophy by
CC       regulating an anti-hypertrophic PKC-mediated signaling pathway. May
CC       regulate the organization of myofibrils through TTN in muscle cells.
CC       {ECO:0000269|PubMed:11679633, ECO:0000269|PubMed:15596539}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27;
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Homodimer. Homooligomer and heterooligomer. Interacts with
CC       SUMO2, titin/TTN and GMEB1. Interacts with TRIM54 and probably with
CC       TRIM55 and TNNI3. Forms a ternary complex with RACK1 and PRKCE.
CC       Interacts with CKM (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.
CC       Cytoplasm, myofibril, sarcomere, M line {ECO:0000250}. Cytoplasm,
CC       myofibril, sarcomere, Z line {ECO:0000269|PubMed:11927605}.
CC       Note=Colocalizes with TNNI3 in myocytes. Localizes to the M- and Z-
CC       lines in skeletal muscle (By similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Muscle specific. Selectively expressed in heart and
CC       skeletal muscle. {ECO:0000269|PubMed:11679633}.
CC   -!- INDUCTION: By interleukin-1, dexamethasone, lipolysaccharide and
CC       indinavir. Up-regulated upon muscle denervation, immobilization and
CC       unweighting and more generally upon muscle atrophy. Up-regulated upon
CC       sepsis. Down-regulated upon aging. {ECO:0000269|PubMed:11679633,
CC       ECO:0000269|PubMed:12672461, ECO:0000269|PubMed:12782319,
CC       ECO:0000269|PubMed:14718385, ECO:0000269|PubMed:15827064,
CC       ECO:0000269|PubMed:15963672}.
CC   -!- DOMAIN: The RING-type zinc finger mediates interaction with SUMO2 and
CC       localization to the nucleus. Also required for the E3 ubiquitin ligase
CC       activity (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The B box-type zinc finger mediates homodimerization.
CC       {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY059627; AAL16405.1; -; mRNA.
DR   EMBL; BC061824; AAH61824.1; -; mRNA.
DR   RefSeq; NP_543179.1; NM_080903.1.
DR   AlphaFoldDB; Q91Z63; -.
DR   SMR; Q91Z63; -.
DR   BioGRID; 250873; 8.
DR   IntAct; Q91Z63; 1.
DR   STRING; 10116.ENSRNOP00000058869; -.
DR   PhosphoSitePlus; Q91Z63; -.
DR   PaxDb; 10116-ENSRNOP00000058869; -.
DR   DNASU; 140939; -.
DR   Ensembl; ENSRNOT00000067524.4; ENSRNOP00000058869.1; ENSRNOG00000016543.8.
DR   Ensembl; ENSRNOT00055042390; ENSRNOP00055034617; ENSRNOG00055024636.
DR   Ensembl; ENSRNOT00060055110; ENSRNOP00060045555; ENSRNOG00060031813.
DR   GeneID; 140939; -.
DR   KEGG; rno:140939; -.
DR   UCSC; RGD:619964; rat.
DR   AGR; RGD:619964; -.
DR   CTD; 84676; -.
DR   RGD; 619964; Trim63.
DR   eggNOG; KOG2177; Eukaryota.
DR   GeneTree; ENSGT00940000156529; -.
DR   HOGENOM; CLU_013137_5_1_1; -.
DR   InParanoid; Q91Z63; -.
DR   OMA; NQLEESC; -.
DR   OrthoDB; 5383069at2759; -.
DR   Reactome; R-RNO-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   PRO; PR:Q91Z63; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000016543; Expressed in skeletal muscle tissue and 16 other cell types or tissues.
DR   GO; GO:0043292; C:contractile muscle fiber; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0031430; C:M band; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000151; C:ubiquitin ligase complex; NAS:BHF-UCL.
DR   GO; GO:0030018; C:Z disc; IEA:UniProtKB-SubCell.
DR   GO; GO:0031432; F:titin binding; ISO:RGD.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; ISO:RGD.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; ISO:RGD.
DR   GO; GO:0006936; P:muscle contraction; IDA:MGI.
DR   GO; GO:0010614; P:negative regulation of cardiac muscle hypertrophy; IMP:BHF-UCL.
DR   GO; GO:0045820; P:negative regulation of glycolytic process; ISO:RGD.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISO:RGD.
DR   GO; GO:0006513; P:protein monoubiquitination; ISO:RGD.
DR   GO; GO:0016567; P:protein ubiquitination; IBA:GO_Central.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0014894; P:response to denervation involved in regulation of muscle adaptation; ISO:RGD.
DR   GO; GO:0014878; P:response to electrical stimulus involved in regulation of muscle adaptation; IDA:UniProtKB.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0070555; P:response to interleukin-1; IEP:RGD.
DR   GO; GO:0014732; P:skeletal muscle atrophy; IEP:RGD.
DR   CDD; cd19831; Bbox2_MuRF1_C-II; 1.
DR   CDD; cd16759; RING-HC_MuRF1; 1.
DR   Gene3D; 1.20.5.170; -; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR017903; COS_domain.
DR   InterPro; IPR050143; TRIM/RBCC.
DR   InterPro; IPR042667; TRIM63_RING-HC.
DR   InterPro; IPR027370; Znf-RING_euk.
DR   InterPro; IPR000315; Znf_B-box.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR24103; E3 UBIQUITIN-PROTEIN LIGASE TRIM; 1.
DR   PANTHER; PTHR24103:SF570; E3 UBIQUITIN-PROTEIN LIGASE TRIM63; 1.
DR   Pfam; PF00643; zf-B_box; 1.
DR   Pfam; PF13445; zf-RING_UBOX; 1.
DR   SMART; SM00336; BBOX; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF57845; B-box zinc-binding domain; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS51262; COS; 1.
DR   PROSITE; PS50119; ZF_BBOX; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil; Cytoplasm; Metal-binding; Muscle protein; Nucleus;
KW   Reference proteome; Transferase; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..351
FT                   /note="E3 ubiquitin-protein ligase TRIM63"
FT                   /id="PRO_0000056292"
FT   DOMAIN          267..325
FT                   /note="COS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00586"
FT   ZN_FING         23..79
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   ZN_FING         117..159
FT                   /note="B box-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   REGION          74..218
FT                   /note="Interaction with TTN"
FT                   /evidence="ECO:0000250"
FT   REGION          326..351
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          189..269
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        327..344
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         122
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   BINDING         125
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   BINDING         145
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   BINDING         151
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
SQ   SEQUENCE   351 AA;  39723 MW;  BF906A21340C4D97 CRC64;
     MDYKSGLIPD GNAMENLEKQ LICPICLEMF TKPVVILPCQ HNLCRKCAND IFQAANPYWT
     NRGGSVSMSG GRFRCPSCRH EVIMDRHGVY GLQRNLLVEN IIDIYKQECS SRPLQKGSHP
     MCKEHEDEKI NIYCLTCEVP TCSLCKVFGA HQACEVAPLQ SIFQGQKTEL SNCISMLVAG
     NDRVQTIISQ LEDSCRVTKE NSHQVKEELS HKFDALYAIL DEKKSELLQR ITQEQEEKLD
     FIEALILQYR EQLEKSTKLV ETAIQSLDEP GGATFLLSAK PLIKSIVEAS KGCQLGKTEQ
     GFENMDYFTL NLEHIAEALR AIDFGTDEEE EFTEEEEEED QEEGVSTEGH Q
//
